EMA domperidone safety review will consider 'sudden death' claims
This article was originally published in SRA
Executive Summary
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee will consider claims by the French drug bulletin Prescrire that the anti-emetic drug domperidone may have caused as many as 120 sudden deaths in France alone last year1,2.